Canada House Partners with HelloMD to Increase Practitioner Availability and Provide Convenience to Medical Cannabis Patients...
January 10 2019 - 7:30AM
Canada House Clinics Inc., a division of Canada House Wellness
Group Inc. (CSE:CHV) (“Canada House”) and HelloMD, a leading online
cannabis telehealth company are pleased to announce a new medical
cannabis partnership that supports Canada House’s 2019 growth
through expanded access to practitioner-led advice.
Canada House Clinics will deploy HelloMD’s white-label
telehealth platform to supplement its own practitioner's services
and telemedicine capabilities. The turnkey and on-demand
nature of the HelloMD offering will allow Canada House Clinics to
handle growth spikes when patient demands exceed its own internal
practitioner supply and also take advantage of HelloMD evening and
weekend availability.
“Canada House is committed to helping Canadians interested in
improving their health with cannabinoid therapy,” said Canada House
CEO Chris Churchill-Smith. “This partnership with HelloMD allows us
to expand and better manage our practitioner support for our
patients, while we continue to work with the medical community,
insurers, and governments to improve the medical cannabis program
for all Canadians.”
Canada House patients using this option are greeted by a
co-branded landing page on the HelloMD platform and by HelloMD’s
patient support team prior to being connected with a licenced
practitioner. Qualifying patients are immediately returned to
Canada House and its team of educators to facilitate the patients’
cannabis purchasing decisions.
“Given Canada House’s reputation, especially its unique
strengths in serving the nation’s military veterans, we are
honoured they have chosen HelloMD as an on-demand provider of
online practitioner consults,” said HelloMD’s SVP of Business
Development, Larry Lisser. “We pride ourselves in assisting our
partners to streamline the experience they offer patients and in
doing so, help them to cost-efficiently expand their
operations.”
About Canada House Wellness Group Inc: Canada House is an
experienced, integrated medical cannabis company providing
patient-specific cannabinoid therapy products and services through
its clinics and licensed producer. Canada House is the parent
company of Canada House Clinics Inc., Knalysis Technologies and
Abba Medix Corp. For more information, please visit
www.canadahouse.ca or www.sedar.com.
About HelloMD: HelloMD has facilitated more than 100,000 virtual
consults between medical cannabis patients and licensed
practitioners. The company’s white-label solutions enable third
parties to quickly deploy a turnkey telehealth solution, complete
with the technology, practitioners and support personnel required
to improve their own patient onboarding processes.
For further information about HelloMD: Email:
partners@hellomd.com Visit: https://www.hellomd.com
For Media Inquiries: Garrett Repski, Project Manager, Marigold
Marketing & PR, 1-647-972-2466, garrett@marigoldpr.com
Cautionary Statement Regarding Forward-Looking Information. This
press release contains forward-looking statements, including
statements that relate to, among other things, HelloMD & Canada
House’s clinic, production and technology businesses, its future
plans, HelloMD & Canada House’s markets, objectives, goals,
strategies, intentions, beliefs, expectations and estimates, and
can generally be identified by the use of words such as “may”,
“will”, “could”, “should”, “would”, “likely”, “possible”, “expect”,
“intend”, “estimate”, “anticipate”, “believe”, “plan”, “objective”
and “continue” (or the negative thereof) and words and expressions
of similar import. Although the Company believes that the
expectations reflected in such forward-looking statements are
reasonable, such statements involve risks and uncertainties, and
undue reliance should not be placed on such statements. Certain
material factors or assumptions are applied in making
forward-looking statements, and actual results may differ
materially from those expressed or implied in such statements.
Material assumptions used to develop forward-looking information in
this news release include, among other things, the regulations
related to cannabis use under the Access to Cannabis for Medical
Purposes Regulations and the act respecting cannabis and to amend
the Controlled Drugs and Substances Act, the Criminal Code and
other Acts, passed by the Canadian Federal government, making
cannabis legal for recreational use by October 17, 2018; Company
liquidity and capital resources, including the availability of
additional capital resources to fund its activities; level of
competition; the ability to adapt products and services to the
changing market; the ability to attract and retain key executives;
and the ability to execute strategic plans. Additional information
about material factors that could cause actual results to
differ materially from expectations and about material factors or
assumptions applied in making forward-looking statements may be
found in HelloMD & Canada House’s most recent annual and
interim Management’s Discussion and Analysis under “Risk and
Uncertainties” as well as in other public disclosure documents
filed with Canadian securities regulatory authorities. The Company
does not undertake any obligation to update publicly or to revise
any of the forward-looking statements contained in this document,
whether as a result of new information, future events or otherwise,
except as required by law.
Churchill Ventures Ltd (AMEX:CHV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Churchill Ventures Ltd (AMEX:CHV)
Historical Stock Chart
From Apr 2023 to Apr 2024